News

BriaCell confirms complete resolution of lung metastasis at 4 months in Phase 1/2a trial using Bria-OTS immunotherapy in ...
Q1 2025 Management View Executive Chairman Bill Doyle highlighted the company’s transition to a multi-indication oncology ...
The recent death of actor Val Kilmer from pneumonia complications has brought attention to the dangers of the condition, ...
Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast ...
One of the early signs of lung cancer can be seen on your fingertips - and there's a quick test you can do at home ...
Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.
A program cochair said the agenda was designed to get attendees "out of their comfort zone." The annual meeting runs April 25 ...
DZD8586 study results in B-cell non-Hodgkin lymphomas (B-NHLs) were selected for oral and poster presentations. The analysis ...
AACR's achievement awards and lectureships recognize innovation in basic, translational, clinical, and epidemiological cancer research.
Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.
Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...
The allowed claims in this patent encompass a novel dosing regimen of 200 ppm to 320 ppm gNO for 10 to 45 minutes, 2 to 5 times per day, to provide a nitric oxide-load (NO load) of 300 ppm-hrs to 900 ...